Literature DB >> 35383269

Incretin-induced changes in the transcriptome of skeletal muscles of fa/fa Zucker rat (ZFR) with obesity, without diabetes.

Ides M Colin1, Bernard Knoops2, Anne-Catherine Gérard3,2.   

Abstract

INTRODUCTION: Glucagon-like peptide-1 receptor agonists (GLP-1ra) are increasingly used in treating type 2 diabetes and obesity. Exendin-4 (Ex-4), a long acting GLP-1ra, was previously reported to decrease oxidative stress in hepatocytes, adipocytes and skeletal muscle cells in obese nondiabetic fa/fa Zucker rats (ZFR), thereby improving insulin resistance. AIM: We aimed first to identify Ex-4-induced changes in the transcriptome of skeletal muscle cells in ZFR.
RESULTS: Ontology analysis of differentially expressed genes (DEGs) in ZFR versus lean animals (LR) showed that the extracellular matrix (ECM) is the first most affected cellular compartment, followed by myofibrils and endoplasmic reticulum (ER). Interestingly, among 15 genes regulated in ZFR versus LR, 14 of them were inversely regulated by Ex-4, as further confirmed by RT-qPCR. Picro-Sirius red histological staining showed that decreased ECM fiber area in ZFR is partially restored by Ex-4. Ontology analysis of the myofibril compartment revealed that decreased muscle contractile function in ZFR is partially restored by Ex-4, as confirmed by Phalloidin histological staining that showed a partial restoration by Ex-4 of altered contractile apparatus in ZFR. Ontology analysis of ER DEGs in ZFR versus LR showed that some of them are related to the AMP-activated protein kinase (AMPK) signaling pathway. Phosphorylated AMPK levels were strongly increased in Ex-4-treated ZFR.
CONCLUSION: Altogether, our results suggest that GLP-1ra strongly restructure ECM and reinforce contractile capabilities in ZFR, while optimizing the cellular metabolism through AMPK.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35383269     DOI: 10.1038/s41366-022-01114-2

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.551


  49 in total

Review 1.  Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell.

Authors:  Herbert M Kagan; Wande Li
Journal:  J Cell Biochem       Date:  2003-03-01       Impact factor: 4.429

Review 2.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

3.  Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks.

Authors:  Cole Trapnell; Adam Roberts; Loyal Goff; Geo Pertea; Daehwan Kim; David R Kelley; Harold Pimentel; Steven L Salzberg; John L Rinn; Lior Pachter
Journal:  Nat Protoc       Date:  2012-03-01       Impact factor: 13.491

Review 4.  Structural and functional diversity of lysyl oxidase and the LOX-like proteins.

Authors:  J Molnar; K S K Fong; Q P He; K Hayashi; Y Kim; S F T Fong; B Fogelgren; K Molnarne Szauter; M Mink; K Csiszar
Journal:  Biochim Biophys Acta       Date:  2003-04-11

Review 5.  MANAGEMENT OF ENDOCRINE DISEASE: Are all GLP-1 agonists equal in the treatment of type 2 diabetes?

Authors:  Michael A Nauck; Juris J Meier
Journal:  Eur J Endocrinol       Date:  2019-12       Impact factor: 6.664

Review 6.  Remodelling the extracellular matrix in development and disease.

Authors:  Caroline Bonnans; Jonathan Chou; Zena Werb
Journal:  Nat Rev Mol Cell Biol       Date:  2014-12       Impact factor: 94.444

7.  Bi-allelic Alterations in AEBP1 Lead to Defective Collagen Assembly and Connective Tissue Structure Resulting in a Variant of Ehlers-Danlos Syndrome.

Authors:  Patrick R Blackburn; Zhi Xu; Kathleen E Tumelty; Rose W Zhao; William J Monis; Kimberly G Harris; Jennifer M Gass; Margot A Cousin; Nicole J Boczek; Mario V Mitkov; Mark A Cappel; Clair A Francomano; Joseph E Parisi; Eric W Klee; Eissa Faqeih; Fowzan S Alkuraya; Matthew D Layne; Nazli B McDonnell; Paldeep S Atwal
Journal:  Am J Hum Genet       Date:  2018-03-29       Impact factor: 11.025

Review 8.  Glucagon-like peptide-1 receptor agonists for type 2 diabetes: A rational drug development.

Authors:  Bo Ahrén
Journal:  J Diabetes Investig       Date:  2018-09-17       Impact factor: 4.232

Review 9.  Glucagon-Like Peptide-1 Receptor Analogues in Type 2 Diabetes: Their Use and Differential Features.

Authors:  Katherine A Lyseng-Williamson
Journal:  Clin Drug Investig       Date:  2019-08       Impact factor: 2.859

10.  ToppGene Suite for gene list enrichment analysis and candidate gene prioritization.

Authors:  Jing Chen; Eric E Bardes; Bruce J Aronow; Anil G Jegga
Journal:  Nucleic Acids Res       Date:  2009-05-22       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.